Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages

Go Home

Pharmaceutical Product Life-cycles

Pharmaceutical Product Life-cycles

Nov 5, 2020 | Cases, Health Policy

A leading global pharmaceutical company wanted to understand the interdependencies between resource levels and experience through the life-cycle of drug products. It was also interested in the impact of organisational design on its ability to manage the product pipeline.

In a series of workshops, we developed further an internal qualitative model of the system and produced a quantitative simulation tool for assessment of the likely impact of investment in resources & training. This project model enabled multiple drug products to be evaluated throughout their life-cycle as they affect resource requirements (numbers of people, experience etc) and also to assess the relationships between organisation capabilities and life-cycle progress and success.

The work built on a number of previous engagements with the client and benefited greatly from the experience gained by the modeller and the client team. Using large-scale posters of model overview diagrams, the modelling team were able to bring into the design and development phase a number of senior executives with the experience required in order to gain confidence in the approach.

The organisation now has a quantitative model in which to evaluate the possible impact of investment in resources, training etc on the product portfolio and, ultimately, on profitability. We delivered a comprehensive “cockpit” user interface enabling involvement by non-expert users and model development continues in the light of user feedback.

The effective management of product life-cycles is of critical importance to pharmaceuticals, made worse by the ‘ticking clock’ of the patent life for a drug. Better management of this issue can be worth many millions of dollars for a single product, and since this project enhances decision-making across numerous products, it is delivering very considerable overall value.

Client Anonymous Pharmaceutical Company
Authors/Consultants Jones L (Ventana Systems UK)

Do you want to know more?

More Information

For more information on this case, please contact Lee Jones at Ventana Systems UK.

OTHER SUCCESSFUL APPLICATIONS

Credit Card Giant Halts Market Share Slide With Scenario Planning

Credit Card Giant Halts Market Share Slide With Scenario Planning The Problem MasterCard, a major credit card company, once held a dominant market position US Market Share with only one primary competitor, Visa. They woke up one day and realized that, after six years...

System Dynamics Helps Reduce Waiting Lines for NHS Patients

System Dynamics Helps Reduce Waiting Lines for NHS Patients EXECUTIVE Summary The impact of COVID-19 on the National Health Service (NHS) in England, led to growing record waiting lists, deterioration of patients and recovery of elective care became the number one...

Upcoming Events

Recent Posts

Multisolving Working With Complexity and Interconnection

Multisolving Working With Complexity and Interconnection Climate change. Biodiversity loss. Racial, gender, and economic inequity. Global pandemic and other health crises. Each of these challenges is serious on its own, but they also interact. Inaction on one crisis...

Join us

System Dynamics Admins
System Dynamics Admins